UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 252

Sortiert nach

Biomarkers and clinical predictors of long-term course in obsessivecompulsive disorder: A prospective cohort study

European psychiatry, 2023-03, Vol.66 (S1), p.S231-S231

2023

Volltextzugriff (PDF)

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

British journal of pharmacology, 2009-01, Vol.156 (2), p.338-353

2009

Volltextzugriff (PDF)

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist

British journal of pharmacology, 2009-01, Vol.156 (2), p.338-353

2009

Volltextzugriff (PDF)

F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

British journal of pharmacology, 2009-01, Vol.151 (2), p.237-252

2009

Volltextzugriff (PDF)

New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

Expert opinion on therapeutic patents, 2002-07, Vol.12 (7), p.1047-1071

Cosi, Cristina

2002

Volltextzugriff (PDF)

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Neuropharmacology, 2002-11, Vol.43 (6), p.945

2002

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells

Journal of neuroscience research, 1994-09, Vol.39 (1), p.38-46

1994

Volltextzugriff (PDF)

P.2.d.013 F15599, a post-synaptic cortical preferential 5-HT1A agonist: I) functionally-selective signal transduction profile

European neuropsychopharmacology, 2008, Vol.18, p.S352-S353

2008

Volltextzugriff (PDF)

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia

The international journal of neuropsychopharmacology, 2005-09, Vol.8 (3), p.341-356

2005

Volltextzugriff (PDF)

C-fos mRNA is Spontaneously Induced in the Rat Brain During the Activity Period of the Circadian Cycle

The European journal of neuroscience, 1993-08, Vol.5 (8), p.1071-1078

1993

Volltextzugriff (PDF)

F17464 a new antipsychotic with preferential D3 antagonist, 5-HT1A partial agonist properties. Neurochemical studies

European psychiatry, 2017-04, Vol.41 (S1), p.S807-S807

2017

Volltextzugriff (PDF)

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

European journal of pharmacology, 2006-03, Vol.535 (1), p.135-144

2006

Volltextzugriff (PDF)

Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo : Role of 5-HT1A receptor activation

Brain research, 2005-05, Vol.1043 (1-2), p.32-41

2005

Volltextzugriff (PDF)

Implication of Poly(ADP-Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide

Annals of the New York Academy of Sciences, 1999-12, Vol.890 (1), p.227-239

1999

Volltextzugriff (PDF)

Decreases in mouse brain NAD + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide

Brain research, 1998-10, Vol.809 (1), p.58-67

1998

Volltextzugriff (PDF)

Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT1A receptors expressed in HeLa cells

European journal of pharmacology, 2001-12, Vol.433 (1), p.55-62

2001

Volltextzugriff (PDF)

Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo

Amino acids, 2000-01, Vol.19 (1), p.229-237

2000

Volltextzugriff (PDF)

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Neuropharmacology, 2002-11, Vol.43 (6), p.945-958

2002

Volltextzugriff (PDF)

The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors

European journal of pharmacology, 2000-07, Vol.401 (1), p.9-15

2000

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents

Annals of the New York Academy of Sciences, 1997-10, Vol.825 (1), p.366-379

1997

Volltextzugriff (PDF)

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors

Journal of medicinal chemistry, 1999-05, Vol.42 (9), p.1648-1660

1999

Volltextzugriff (PDF)

Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice

Brain research, 1996-08, Vol.729 (2), p.264-269

Cosi, C

1996

Volltextzugriff (PDF)

Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells

European journal of pharmacology, 2001-12, Vol.433 (1), p.55-62

2001

Volltextzugriff (PDF)

The putative «silent» 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

European journal of pharmacology, 2000-07, Vol.401 (1), p.9-15

2000

Volltextzugriff (PDF)

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

European journal of pharmacology, 2001-05, Vol.420 (2-3), p.103-112

2001

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(220)
Mit Volltextzugriff
(182)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Biomarkers and clinical predictors of long-term course in obsessivecompulsive disorder: A prospective cohort study

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT1A receptor agonist

Signal transduction and functional selectivity of F15599, a preferential post‐synaptic 5‐HT 1A receptor agonist

F15063, a potential antipsychotic with D 2 /D 3 antagonist, 5‐HT 1A agonist and D 4 partial agonist properties: (I) in vitro receptor affinity and efficacy profile

New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Poly(ADP-ribose) polymerase: Early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells

P.2.d.013 F15599, a post-synaptic cortical preferential 5-HT1A agonist: I) functionally-selective signal transduction profile

Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia

C-fos mRNA is Spontaneously Induced in the Rat Brain During the Activity Period of the Circadian Cycle

F17464 a new antipsychotic with preferential D3 antagonist, 5-HT1A partial agonist properties. Neurochemical studies

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo : Role of 5-HT1A receptor activation

Implication of Poly(ADP-Ribose) Polymerase (PARP) in Neurodegeneration and Brain Energy Metabolism: Decreases in Mouse Brain NAD+ and ATP Caused by MPTP Are Prevented by the PARP Inhibitor Benzamide

Decreases in mouse brain NAD + and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide

Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT1A receptors expressed in HeLa cells

Effects of kainic acid lesioning on poly(ADP-ribose) polymerase (PARP) activity in the rat striatum in vivo

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors

Poly(ADP-ribose) polymerase (PARP) revisited. A new role for an old enzyme: PARP involvement in neurodegeneration and PARP inhibitors as possible neuroprotective agents

Novel Derivatives of 2-Pyridinemethylamine as Selective, Potent, and Orally Active Agonists at 5-HT1A Receptors

Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57Bl/6 mice

Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT(1A) receptors expressed in HeLa cells

The putative «silent» 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

5-HT1A receptor activation and antidepressant-like effects : F 13714 has high efficacy and marked antidepressant potential

Suchergebnisse filtern